Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) just released its quarterly report and things are looking bullish. Iovance Biotherapeutics beat expectations with revenues of US$59m arriving 8.8% ahead of ...
Source LinkIovance Biotherapeutics, Inc. (NASDAQ:IOVA) just released its quarterly report and things are looking bullish. Iovance Biotherapeutics beat expectations with revenues of US$59m arriving 8.8% ahead of ...
Source Link
Comments